BioCircuit Technologies

Based in Atlanta, Georgia, BioCircuit Technologies develops noninvasive and minimally invasive electrophysiology devices designed for peripheral nerve management, repair, and continuous monitoring. The company provides clinical hospitals, orthopedic surgeons, and neurologists across the United States with proprietary products like Nerve Tape, a sutureless nerve repair implant, and the Eval system for evaluating muscle function. Operating with fewer than 500 employees, the medical device manufacturer has raised $9 million in venture funding and secured over $7 million in research grants from the National Institutes of Health. Under the leadership of Chief Executive Officer Michelle Jarrard and Chief Technology Officer Isaac Clements, the enterprise successfully received FDA clearance for its primary nerve repair device in late 2022. BioCircuit Technologies was originally founded in 2016 by the entrepreneurial team of Jack Griffis, Jim Ross, and Tom O'Brien.